Biotechnology and bioengineering – Page 14
-
Business
Gene therapy gathers pace
Sarah Houlton charts the evolution, challenges and opportunities of cell and gene therapy
-
-
Review
Seeds of science: why we got it so wrong on GMOs
Katrina Kramer reviews the story of one man’s journey from activist to advocate
-
Research
Optogenetic control puts biosynthesis into – and out of – the spotlight
Using light to switch which enzymes brewer’s yeast produces boosts concentrations of biofuel candidate isobutanol fivefold.
-
Research
Bacteria churn out a million potential protein drugs
Modified bacteria produce enormous library of macrocycles, one of which inhibits a HIV protein
-
Feature
Cuba: socialism, cigars and biotech
Nina Notman learns how biotechnology could potentially overtake cigars as Cuba’s most famous export
-
Article
The ever-increasing attraction of biologics
Biologics promise targeted treatments for a range of conditions – if we can overcome the technological challenges
-
Research
Tofu works as tissue-engineering scaffold
Garlic, ginger and chilli swapped for fibroblast cells
-
Research
Antimalarial plant's chlorophyll catalyses drug synthesis
New ‘green’ method makes malaria-fighting artemisinin’s synthesis faster and cheaper with industrial production planned for 2021
-
Research
Nucleus infiltrated by peptide gene switch
Synthetic peptides used to control cellular processes
-
Research
Human genome sequenced by handheld device
MinION nanopore sequencer fills in gaps in our knowledge of genome
-
-
News
Explainer: non-alcoholic beer and wine
For Dry January and beyond, drinkers are thirsty for beers and wines that don’t get you drunk
-
Research
Indigo genes dyeing to make jeans cleaner and greener
Denim dye could become more environmentally friendly with some clever chemistry
-
Research
Synthetic gene cost slashed to $2
DropSynth makes hundreds of strands in a single tube, boosting tests of gene function
-
-
Research
Scrutiny of SmartFlares raises questions over RNA probes
Merck Millipore technology for detecting specific RNAs may not live up to claims
-
Research
Error-free next-generation DNA sequencing pioneered
Algorithmic fix allows ultra-accurate sequencing of rare cancers and genetic conditions
-
Business
Lilly and CureVac to collaborate on mRNA cancer vaccines
Deal could see CureVac net up to $1.8 billion in upfront and milestone payments